Cul­li­nan's deal for T cell en­gager from Chi­na; Kardi­gan buys late-stage heart drug

Plus, news about No­var­tis, Sig­ni­fy Bio, Ocu­gen, Dy­navax and Vi­Gen­eron:

Cul­li­nan Ther­a­peu­tics gets rights to T cell en­gager de­vel­oped in Chi­na: The com­pa­ny

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER